Journal of Pharmacy And Bioallied Sciences

: 2012  |  Volume : 4  |  Issue : 4  |  Page : 257-

Journal of Pharmacy and Bio Allied Sciences Vol 4 Issue 4

Mohd Aqil 
 Department of Pharmaceutics, Jamia Hamdard University, New Delhi, India

Correspondence Address:
Mohd Aqil
Department of Pharmaceutics, Jamia Hamdard University, New Delhi

How to cite this article:
Aqil M. Journal of Pharmacy and Bio Allied Sciences Vol 4 Issue 4.J Pharm Bioall Sci 2012;4:257-257

How to cite this URL:
Aqil M. Journal of Pharmacy and Bio Allied Sciences Vol 4 Issue 4. J Pharm Bioall Sci [serial online] 2012 [cited 2022 Aug 16 ];4:257-257
Available from:

Full Text

We are pleased to present before you the 4 th issue of JPBS in the year 2012. Today, JPBS receives quality articles from all over the world and is becoming an important fast medium for reporting recent developments in pharmacy and allied sciences. Many pharma communities, academic scientists, R&D professionals, educators, and clinicians have supported us in our continuous progress and future endeavors.

We in the editorial team believe, as a researcher, you can make lasting and valuable contributions to the health and future of society, and therefore we are always keen to publish good quality, ethically written articles. Publishing ethically based on systematically and rationally collected laboratory data ensure that we have trusted information on which to build future therapies, technologies, and policies. Also published work based on fraudulent data can form inappropriate basis for follow-up studies leading to waste of resources and may be detrimental to patients and communities.

In this issue, we have covered articles and reviews from different subjects such as Pharmaceutical Sciences, Nanotechnology, Biotechnology, Chemistry, Clinical Regulations, etc. I hope these articles will not only add to your knowledge base but also stimulate your thought process in research. As mentioned in our past editorials, we are looking forward to enhance the quality of the journal and increase our subscription base globally; we invite your valuable suggestions and comments at [email protected] in this regard.